Sonoma Pharmaceuticals Inc expected to post a loss of 17 cents a share - Earnings Preview

Sonoma Pharmaceuticals

09/02/2024 22:42

* Sonoma Pharmaceuticals Inc  SNOA.OQ   SNOA.O  is expected
to report results for the period ending March 31 2024
    * The Boulder Colorado-based  company is expected to report
revenue of $3.98 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Sonoma Pharmaceuticals
Inc is
for a loss of 17 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sonoma
Pharmaceuticals Inc is $3.25​, above​ its last closing price
of $0.16. ​​​

This summary was machine generated February 9 at 22:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)